EUVIMEDScopri EUVIMED
Open access

CRISPR/Cas9‐Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells

Arun Sharma, Christopher N Toepfer, Tarsha Ward, Lauren Wasson, Radhika Agarwal, David A Conner, Johnny H Hu, Christine E Seidman

Current Protocols in Human Genetics · 2018-01 · 96 (1)

DOI: 10.1002/cphg.52 ↗

At a glance

Journal article in Current Protocols in Human Genetics, published online on 2018-01-24. Written by Arun Sharma and 7 co-authors. Institution: Department of Genetics, Harvard Medical School, Boston, Massachusetts. Major MEDLINE topics: Genetic Therapy. Cited 55 times so far (Crossref); 29 references. The full text is freely available in PubMed Central. Funded by: Howard Hughes Medical Institute, NHLBI NIH HHS, Wellcome Trust.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Human induced pluripotent stem cells (hiPSCs) can be used to mass produce surrogates of human tissues, enabling new advances in drug screening, disease modeling, and cell therapy. Recent developments in clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 genome editing technology use homology‐directed repair (HDR) to efficiently generate custom hiPSC lines harboring a variety of genomic insertions and deletions. Thus, hiPSCs that encode an endogenous protein fused to a fluorescent reporter protein can be rapidly created by employing CRISPR/Cas9 genome editing, enhancing HDR efficiency and optimizing homology arm length. These fluorescently tagged hiPSCs can be used to visualize protein function and dynamics in real time as cells proliferate and differentiate. Given that nearly any intracellular protein can be fluorescently tagged, this system serves as a powerful tool to facilitate new discoveries across many biological disciplines. In this unit, we present protocols for the design, generation, and monoclonal expansion of genetically customized hiPSCs encoding fluorescently tagged endogenous proteins. © 2018 by John Wiley & Sons, Inc.

Subjects

MeSH terms (MEDLINE)

Genetic TherapyCRISPR-Cas SystemsFluorescenceGene EditingGenome, HumanHumansInduced Pluripotent Stem CellsRecombinational DNA Repair

Author keywords

CRISPRfluorescent reportersgenome editingpluripotent stem cellssynthetic biology

Authors and institutions

  • Department of Genetics, Harvard Medical School, Boston, Massachusetts.
  • Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts.

Funding

  • Howard Hughes Medical Institute
  • NHLBI NIH HHS
  • Wellcome Trust

Cite

APA

Sharma, A., Toepfer, C. N., Ward, T., Wasson, L., Agarwal, R., Conner, D. A., Hu, J. H., & Seidman, C. E. (2018). CRISPR/Cas9‐Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells. Current Protocols in Human Genetics, 96(1). https://doi.org/10.1002/cphg.52

Vancouver

Sharma A, Toepfer CN, Ward T, Wasson L, Agarwal R, Conner DA, et al. CRISPR/Cas9‐Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells. Current Protocols in Human Genetics. 2018;96(1). doi:10.1002/cphg.52

BibTeX
@article{Sharma2018,
  author = {Sharma, Arun and Toepfer, Christopher N and Ward, Tarsha and Wasson, Lauren and Agarwal, Radhika and Conner, David A and Hu, Johnny H and Seidman, Christine E},
  title = {CRISPR/Cas9‐Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells},
  journal = {Current Protocols in Human Genetics},
  year = {2018},
  volume = {96},
  number = {1},
  doi = {10.1002/cphg.52}
}
Start for free →